Clinical Trials Browser

Phase 2 × Neoplasms × veliparib × Clear all

NCT01042379 2026-05-06

I-SPY

Phase 2 Recruiting

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT03044795 2024-05-03

REPAIR

Phase 2 Withdrawn

Neoplasms

NCT01193140 2012-11-21

To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors

Phase 2 Completed

Neoplasms, Recurrence